Not applicableWithdrawnNCT06692153What this trial is testingEmbecta AID System in Adults With Type 2 DiabetesWho this might be right forType 2 DiabetesType 2 Diabetes Mellitus (T2DM)Type 2 DM+4 more Embecta Corp.
Testing effectiveness (Phase 2)Study completedNCT03317028What this trial is testingCS02 vs Placebo With Metformin in Type 2 Diabetes Mellitus (T2DM)Who this might be right forT2DM With Inadequate Glycemic Control Center Laboratories, Inc. 201
Large-scale testing (Phase 3)Ended earlyNCT04754334What this trial is testingEvaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes MellitusWho this might be right forT2DM (Type 2 Diabetes Mellitus) Oramed, Ltd. 346
Testing effectiveness (Phase 2)Study completedNCT03467932What this trial is testingEvaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes MellitusWho this might be right forT2DM (Type 2 Diabetes Mellitus) Oramed, Ltd. 373
Large-scale testing (Phase 3)Study completedNCT01177384What this trial is testingClinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130)Who this might be right forType 2 Diabetes Mellitus Merck Sharp & Dohme LLC 380
Early research (Phase 1)Study completedNCT00704132What this trial is testingSitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059)Who this might be right forType 2 Diabetes Mellitus (T2DM) Merck Sharp & Dohme LLC 57
Large-scale testing (Phase 3)UnknownNCT03851432What this trial is testingJanagliflozin Treat Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With MetforminWho this might be right forDiabetes Mellitus, Type 2 Sihuan Pharmaceutical Holdings Group Ltd. 390
Large-scale testing (Phase 3)Study completedNCT00337610What this trial is testingSitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes MellitusWho this might be right forType 2 Diabetes Mellitus (T2DM) Merck Sharp & Dohme LLC 190
Post-approval studies (Phase 4)Study completedNCT00833027What this trial is testingALPHA Sitagliptin Add on to Metformin (0431-103)Who this might be right forDiabetes Mellitus Merck Sharp & Dohme LLC 608
Large-scale testing (Phase 3)Study completedNCT01717313What this trial is testingAssess the Safety and Efficacy of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (T2DM) and Inadequate Glycemic Control (MK-3102-011)Who this might be right forType 2 Diabetes Mellitus Merck Sharp & Dohme LLC 329
Large-scale testing (Phase 3)Study completedNCT02532855What this trial is testingAssess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)Who this might be right forType 2 Diabetes Mellitus Merck Sharp & Dohme LLC 614
Testing effectiveness (Phase 2)Active Not RecruitingNCT07055386What this trial is testingCompare the Efficacy and Safety of GZR102 Injection and GZR18 Injection in Type 2 Diabetes MellitusWho this might be right forType 2 Diabetes Mellitus (T2DM) Gan & Lee Pharmaceuticals. 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07139405What this trial is testingTRIGLYTZA® VERSUS METFORMIN IN OBESE ADULT TYPE 2 DIABETES (T2DM) PATIENTS OVER 24 WEEKS OF TREATMENTWho this might be right forType 2 Diabetes (T2DM) Myopharm Limited 90
Large-scale testing (Phase 3)Ended earlyNCT01678820What this trial is testingThe Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266)Who this might be right forType 2 Diabetes Mellitus Merck Sharp & Dohme LLC 299
Large-scale testing (Phase 3)Study completedNCT01702298What this trial is testingAssess the Safety and Tolerability of Sitagliptin/Simvastatin Fixed-dose Combination (FDC) in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-312)Who this might be right forType 2 Diabetes Mellitus Merck Sharp & Dohme LLC 42
Large-scale testing (Phase 3)Ended earlyNCT03608358What this trial is testingSafety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/SaxagliptinWho this might be right forType 2 Diabetes Mellitus AstraZeneca 41
Large-scale testing (Phase 3)Study completedNCT01590771What this trial is testingA Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Sulfonylurea With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-253)Who this might be right forType 2 Diabetes Mellitus Merck Sharp & Dohme LLC 498
Large-scale testing (Phase 3)Study completedNCT04634500What this trial is testingThe Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes.Who this might be right forT2DM (Type 2 Diabetes Mellitus) Daewoong Pharmaceutical Co. LTD. 200
Large-scale testing (Phase 3)Study completedNCT02226003What this trial is testingEfficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017)Who this might be right forType 2 Diabetes Mellitus Merck Sharp & Dohme LLC 291
Large-scale testing (Phase 3)Not Yet RecruitingNCT06731075What this trial is testingEvaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus.Who this might be right forType 2 Diabetes Mellitus Oramed, Ltd. 300